Additional exercise therapy in patients with peripheral arterial disease: The value of supervised exercise therapy after invasive treatment of peripheral arterial disease.

Additional exercise therapy in patients with peripheral arterial disease: The value of supervised exercise therapy after invasive treatment of peripheral arterial disease. - NETP Extra

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON30240

Enrollment

Registered

2007-01-04

Start date

2007-02-16

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intermittent claudication Peripheral arterial disease

Interventions

For 12 months the intervention group receives exercise therapy with supervision from a trained physiotherapist, according to the protocol of the Royal Dutch Society of Physiotherapists.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with peripheral arterial disease, fontaine stadium 2, 3, or 4, with an indication for angioplasty or surgical reconstruction

Exclusion criteria

Exclusion criteria: Disability to exercise as a result of peripheral arterial disease, serieus cardiac or pulmonary comorbidity (NYHA 3 and 4), other comorbidities that disable exercise therapy and inadequate knowledge of the Dutch language

Design outcomes

Primary

Measure	Time frame
The primary outcome is the absolute claudication distance in meters. This is the distance at which a patient can not walk any further, and is determined by a standard treadmill protocol.	—

Secondary

Measure	Time frame
Additional outcomes are initial claudication distance, quality of life, fontaine stadium, ankle brachial index, vascular risk factors, re-interventions, number of attended sessions, patency and mortality.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)